Clinical efficacy and safety of combined treatment of terbutaline and budesonide in the treatment of chronic obstructive pulmonary disease
Objective To observe the effect of combined treatment of terbutaline and budesonide in the treatment of patients with chronic obstructive pulmonary disease.Methods 60 patients with chronic obstructive pulmonary disease were selected and divided into an experimental group(30 cases)and a control group(30 cases)by random number table method.The experimental group received combined treatment of terbutaline and budesonide as intervention measures,and the control group received budesonide treatment as intervention measures.The therapeutic effect,incidence of adverse reactions and quality of life score were compared between the two groups.Results After treatment,the total effective rate of the experimental group(93.33%)was higher than that of the control group(70.00%)(P<0.05).After treatment,the incidence of adverse reactions in the experimental group(3.33%)was lower than that in the control group(23.33%)(P<0.05).Before treatment,there were no significant differences in psychological function score,material life status score and social function score between the two groups(P>0.05).After treatment,the experimental group had pychological function score of(80.16±4.28)points,material life status score of(81.28±4.61)points and social function score of(80.13±3.24)points,which were higher than(71.37±4.64),(72.13±4.62)and(70.92±3.13)points in the control group(P<0.05).Conclusion The combined treatment of terbutaline and budesonide in the treatment of clinical chronic obstructive pulmonary disease patients has been shown to be more effective,with better symptomatic relief,fewer adverse effects,and higher quality of life,which is worthy of clinical application.
NETL
NSTL
万方数据
